Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update

An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity

(2011) Penélope D. Sánchez-González et al.   CRITICAL REVIEWS IN TOXICOLOGY

Protective effect of erythropoietin against cisplatin-induced nephrotoxicity in rats: antigenotoxic and antiapoptotic effect

(2011) Karima Rjiba-Touati et al.   DRUG AND CHEMICAL TOXICOLOGY

Drug transporters of platinum-based anticancer agents and their clinical significance

(2011) Herman Burger et al.   DRUG RESISTANCE UPDATES

Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer

(2011) Navjotsingh Pabla et al.   JOURNAL OF CLINICAL INVESTIGATION

Chemotherapy in advanced bladder cancer: current status and future

(2011) Nabil Ismaili et al.   Journal of Hematology & Oncology

Accumulation of BNP7787 in Human Renal Proximal Tubule Cells

(2011) F.H. Hausheer et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity

(2011) P. D. Sanchez-Gonzalez et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rôle de la chimiothérapie dans la prise en charge du cancer de la vessie

(2011) N. Ismaili et al.   PROGRES EN UROLOGIE

Update on Malignant Pleural Mesothelioma

(2011) Nicholas Campbell et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Ischemic kidney injury and mechanisms of tissue repair

(2011) Marwa El Sabbahy et al.   Wiley Interdisciplinary Reviews-Systems Biology and Medicine

Protecting Cisplatin-Induced Nephrotoxicity with Cimetidine Does Not Affect Antitumor Activity

(2010) Hiromu Katsuda et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N

(2010) F. H. Hausheer et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway

(2010) O. Vondalova Blanarova et al.   CARCINOGENESIS

Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria

(2010) M.A. Carvalho Rodrigues et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Pituitary Adenylate Cyclase-Activating Polypeptide Prevents Cisplatin-Induced Renal Failure

(2010) Min Li et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Systematic Review

(2010) John Goffin et al.   Journal of Thoracic Oncology

Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis

(2010) Zhanjun Jia et al.   KIDNEY INTERNATIONAL

Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2

(2009) Yuko Tanihara et al.   BIOCHEMICAL PHARMACOLOGY

Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma

(2009) Howard M. Katzenstein et al.   CANCER

Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase

(2009) Frederick H. Hausheer et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Protective Effects of the Angiotensin II Receptor Blocker Losartan on Cisplatin-Induced Kidney Injury

(2009) Samira Saleh et al.   CHEMOTHERAPY

Enhancement of Lexatumumab-Induced Apoptosis in Human Solid Cancer Cells by Cisplatin in Caspase-Dependent Manner

(2009) X.-X. Wu et al.   CLINICAL CANCER RESEARCH

Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice

(2009) T.A. Ajith et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Functional TauT Protects Against Acute Kidney Injury

(2009) X. Han et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Carvedilol protects against the renal mitochondrial toxicity induced by cisplatin in rats

(2009) M.A. Carvalho Rodrigues et al.   MITOCHONDRION

 -Lipoic acid prevents cisplatin-induced acute kidney injury in rats

(2009) E. H. Bae et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury

(2009) Min Li et al.   PEPTIDES

Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role

(2009) C William Helm et al.   Journal of Ovarian Research

The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography???inductively coupled plasma mass spectrometry

(2008) Elke E.M. Brouwers et al.   ANTI-CANCER DRUGS

Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care

(2008) Vincent Launay-Vacher et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity

(2008) M. Jiang et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Tumor Necrosis Factor-α Induces Intrinsic Apoptotic Signaling During Renal Obstruction Through Truncated Bid Activation

(2008) Matthew T. Campbell et al.   JOURNAL OF UROLOGY

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

(2008) N. Pabla et al.   KIDNEY INTERNATIONAL

Antioxidants

(2008) Jay L. Koyner et al.   NEPHRON EXPERIMENTAL NEPHROLOGY

Protective Effects of Vitamin C on Cisplatin-Induced Renal Damage: A Light and Electron Microscopic Study

(2008) Yeter Topcu Tarladacalisir et al.   RENAL FAILURE

Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway

(2008) Richard D. Wainford et al.   TOXICOLOGY